The role of the multidisciplinary team in antifungal stewardship

Samir Agrawal, Rosemary Barnes, Roger J. Bruggemann, Riina Rautemaa-Richardson, Aafje Warris

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

There are a variety of challenges faced in the management of invasive fungal diseases (IFD), including high case-fatality rates, high cost of antifungal drugs and development of antifungal resistance. The diagnostic challenges and poor outcomes associated with IFD have resulted in excessive empirical use of antifungals in various hospital settings, exposing many patients without IFD to potential drug toxicities as well as causing spiralling antifungal drug costs. Further complexity arises as different patient groups show marked variation in their risk for IFD, fungal epidemiology, sensitivity and specificity of diagnostic tests and the pharmacokinetics and pharmacodynamics of antifungal drugs. To address these issues and to ensure optimal management of IFD, specialist knowledge and experience from a range of backgrounds is required, which extends beyond the remit of most antibiotic stewardship programmes. The first step in the development of any antifungal stewardship (AFS) programme is to build a multidisciplinary team encompassing the necessary expertise in the management of IFD to develop and implement the AFS programme. The specific roles of the key individuals within the AFS team and the importance of collaboration are discussed in this article.
Original languageEnglish
Pages (from-to)ii37-ii42
Number of pages6
JournalJournal of Antimicrobial Chemotherapy
Volume71
Issue numberSuppl. 2
DOIs
Publication statusPublished - Nov 2016

Fingerprint

Mycoses
Fungal Drug Resistance
Drug Costs
Drug-Related Side Effects and Adverse Reactions
Routine Diagnostic Tests
Epidemiology
Pharmacokinetics
Anti-Bacterial Agents
Costs and Cost Analysis
Sensitivity and Specificity
Mortality
Pharmaceutical Preparations

Cite this

Agrawal, S., Barnes, R., Bruggemann, R. J., Rautemaa-Richardson, R., & Warris, A. (2016). The role of the multidisciplinary team in antifungal stewardship. Journal of Antimicrobial Chemotherapy, 71(Suppl. 2), ii37-ii42. https://doi.org/10.1093/jac/dkw395

The role of the multidisciplinary team in antifungal stewardship. / Agrawal, Samir ; Barnes, Rosemary; Bruggemann, Roger J.; Rautemaa-Richardson, Riina ; Warris, Aafje.

In: Journal of Antimicrobial Chemotherapy, Vol. 71, No. Suppl. 2, 11.2016, p. ii37-ii42.

Research output: Contribution to journalArticle

Agrawal, S, Barnes, R, Bruggemann, RJ, Rautemaa-Richardson, R & Warris, A 2016, 'The role of the multidisciplinary team in antifungal stewardship', Journal of Antimicrobial Chemotherapy, vol. 71, no. Suppl. 2, pp. ii37-ii42. https://doi.org/10.1093/jac/dkw395
Agrawal S, Barnes R, Bruggemann RJ, Rautemaa-Richardson R, Warris A. The role of the multidisciplinary team in antifungal stewardship. Journal of Antimicrobial Chemotherapy. 2016 Nov;71(Suppl. 2):ii37-ii42. https://doi.org/10.1093/jac/dkw395
Agrawal, Samir ; Barnes, Rosemary ; Bruggemann, Roger J. ; Rautemaa-Richardson, Riina ; Warris, Aafje. / The role of the multidisciplinary team in antifungal stewardship. In: Journal of Antimicrobial Chemotherapy. 2016 ; Vol. 71, No. Suppl. 2. pp. ii37-ii42.
@article{e7b68b21796a4a60b859a7e1acab7903,
title = "The role of the multidisciplinary team in antifungal stewardship",
abstract = "There are a variety of challenges faced in the management of invasive fungal diseases (IFD), including high case-fatality rates, high cost of antifungal drugs and development of antifungal resistance. The diagnostic challenges and poor outcomes associated with IFD have resulted in excessive empirical use of antifungals in various hospital settings, exposing many patients without IFD to potential drug toxicities as well as causing spiralling antifungal drug costs. Further complexity arises as different patient groups show marked variation in their risk for IFD, fungal epidemiology, sensitivity and specificity of diagnostic tests and the pharmacokinetics and pharmacodynamics of antifungal drugs. To address these issues and to ensure optimal management of IFD, specialist knowledge and experience from a range of backgrounds is required, which extends beyond the remit of most antibiotic stewardship programmes. The first step in the development of any antifungal stewardship (AFS) programme is to build a multidisciplinary team encompassing the necessary expertise in the management of IFD to develop and implement the AFS programme. The specific roles of the key individuals within the AFS team and the importance of collaboration are discussed in this article.",
author = "Samir Agrawal and Rosemary Barnes and Bruggemann, {Roger J.} and Riina Rautemaa-Richardson and Aafje Warris",
note = "A. W. has received consultancy fees from Basilea and Gilead; educational grants from Pfizer and Gilead; and is supported by the Wellcome Trust Strategic Award for Medical Mycology and Fungal Immunology 097377. This article forms part of a Supplement sponsored and funded by Gilead Sciences Europe Ltd; editorial assistance was provided by Synergy Medical. The content of this Supplement is based on the sessions presented at the CARE VIII meeting, held in Madrid in November 2015.",
year = "2016",
month = "11",
doi = "10.1093/jac/dkw395",
language = "English",
volume = "71",
pages = "ii37--ii42",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "Suppl. 2",

}

TY - JOUR

T1 - The role of the multidisciplinary team in antifungal stewardship

AU - Agrawal, Samir

AU - Barnes, Rosemary

AU - Bruggemann, Roger J.

AU - Rautemaa-Richardson, Riina

AU - Warris, Aafje

N1 - A. W. has received consultancy fees from Basilea and Gilead; educational grants from Pfizer and Gilead; and is supported by the Wellcome Trust Strategic Award for Medical Mycology and Fungal Immunology 097377. This article forms part of a Supplement sponsored and funded by Gilead Sciences Europe Ltd; editorial assistance was provided by Synergy Medical. The content of this Supplement is based on the sessions presented at the CARE VIII meeting, held in Madrid in November 2015.

PY - 2016/11

Y1 - 2016/11

N2 - There are a variety of challenges faced in the management of invasive fungal diseases (IFD), including high case-fatality rates, high cost of antifungal drugs and development of antifungal resistance. The diagnostic challenges and poor outcomes associated with IFD have resulted in excessive empirical use of antifungals in various hospital settings, exposing many patients without IFD to potential drug toxicities as well as causing spiralling antifungal drug costs. Further complexity arises as different patient groups show marked variation in their risk for IFD, fungal epidemiology, sensitivity and specificity of diagnostic tests and the pharmacokinetics and pharmacodynamics of antifungal drugs. To address these issues and to ensure optimal management of IFD, specialist knowledge and experience from a range of backgrounds is required, which extends beyond the remit of most antibiotic stewardship programmes. The first step in the development of any antifungal stewardship (AFS) programme is to build a multidisciplinary team encompassing the necessary expertise in the management of IFD to develop and implement the AFS programme. The specific roles of the key individuals within the AFS team and the importance of collaboration are discussed in this article.

AB - There are a variety of challenges faced in the management of invasive fungal diseases (IFD), including high case-fatality rates, high cost of antifungal drugs and development of antifungal resistance. The diagnostic challenges and poor outcomes associated with IFD have resulted in excessive empirical use of antifungals in various hospital settings, exposing many patients without IFD to potential drug toxicities as well as causing spiralling antifungal drug costs. Further complexity arises as different patient groups show marked variation in their risk for IFD, fungal epidemiology, sensitivity and specificity of diagnostic tests and the pharmacokinetics and pharmacodynamics of antifungal drugs. To address these issues and to ensure optimal management of IFD, specialist knowledge and experience from a range of backgrounds is required, which extends beyond the remit of most antibiotic stewardship programmes. The first step in the development of any antifungal stewardship (AFS) programme is to build a multidisciplinary team encompassing the necessary expertise in the management of IFD to develop and implement the AFS programme. The specific roles of the key individuals within the AFS team and the importance of collaboration are discussed in this article.

U2 - 10.1093/jac/dkw395

DO - 10.1093/jac/dkw395

M3 - Article

VL - 71

SP - ii37-ii42

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - Suppl. 2

ER -